Yuan Tian
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Yuan Tian is currently the Chairman and Chief Executive Officer at CIFCO International Group since 2007.
Prior to this, he was the Chairman at China International Futures Co., Ltd. He also served as a Non-Executive Director at Quam Plus International Financial Ltd. from 2006 to 2008.
Additionally, he was a Director at ContraFect Corp.
and a Non-Executive Director at Ascentage Pharma Group International Co., Ltd. Dr. Tian holds a doctorate degree from Wuhan University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
CIFCO International Group
CIFCO International Group Investment ManagersFinance Provides financial advisory services | Directeur Général | 01/01/2007 |
| Sociétés | Poste | Fin |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Directeur/Membre du Conseil | 20/05/2022 |
| QUAM PLUS INTERNATIONAL FINANCIAL LIMITED | Directeur/Membre du Conseil | 11/09/2008 |
| CONTRAFECT CORPORATION | Directeur/Membre du Conseil | - |
China International Futures Co., Ltd.
China International Futures Co., Ltd. Investment Banks/BrokersFinance Provides commodities trading services | Président | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Quam Plus International Financial Ltd.
Quam Plus International Financial Ltd. Investment Banks/BrokersFinance Provides securities brokerage, financial advisory, and fund management services | Finance |
Wuhan University
Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China International Futures Co., Ltd.
China International Futures Co., Ltd. Investment Banks/BrokersFinance Provides commodities trading services | Finance |
ContraFect Corp.
ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
CIFCO International Group
CIFCO International Group Investment ManagersFinance Provides financial advisory services | Finance |
Ascentage Pharma Group International Co., Ltd.
Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national